BOTOX Cosmetic
- Company typePrivate
- Founded2002
- HeadquartersIrvine, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
BOTOX Cosmetic firmographics
Firmographics- Name
- BOTOX Cosmetic
- Legal name
- BOTOX Cosmetic (Product Brand owned by Allergan Aesthetics, a subsidiary of AbbVie Inc.)
- Website
- https://botoxcosmetic.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
BOTOX Cosmetic industry classification
Industry- Product category
- Aesthetic Neurotoxin Injectables
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Medicinal and Botanical Manufacturing (325411)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)
Keywords
Where BOTOX Cosmetic is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BOTOX Cosmetic business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Marketing or Sales, Operations, Technology or R&D, Personnel, Supply Chain, Infrastructure
Revenue model
- Prescription Injectable Sales: BOTOX Cosmetic is sold as a prescription medicine to licensed medical providers who then administer treatments to patients. The product is a prescription injectable that providers purchase and administer to consumers seeking treatment for facial lines.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | The Look of 3 treatment - 64 units for forehead lines, frown lines, and crow's feet |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
BOTOX Cosmetic product offering
Product offeringCore offering
BOTOX Cosmetic (onabotulinumtoxinA) is a prescription injectable treatment that temporarily reduces underlying muscle activity to improve the appearance of moderate to severe frown lines, crow's feet, forehead lines, and vertical bands connecting the neck and jaw (platysma bands) in adults. The product is manufactured using a proprietary process and administered by licensed medical specialists in 10–15 minute sessions with minimal downtime, with results visible in 24–48 hours and full results within 14–30 days.
Product overview
BOTOX Cosmetic is a single prescription injectable medication (onabotulinumtoxinA) that is the original and only FDA-approved product of its kind for over 20 years. The core product is supplemented by The Look of 3® treatment protocol (a 64-unit, 3-area treatment plan), the Allē loyalty program for patient rewards and savings, and The Confidence Collective initiative supporting women entrepreneurs. The main product treats four areas: forehead lines, frown lines, crow's feet, and vertical bands connecting the neck and jaw.
Differentiator
Problem solved
Functional benefit
Brands
- Allē: The leading aesthetics loyalty program in the US, by the makers of BOTOX Cosmetic. Allows members to earn points on BOTOX Cosmetic treatments and over 50 other products and treatments, redeemable for savings on qualifying injectables and Skinmedica products.
Products and services
- BOTOX® Cosmetic (onabotulinumtoxinA) A prescription injectable treatment that temporarily reduces underlying muscle activity to improve the appearance of moderate to severe frown lines, crow's feet, forehead lines, and vertical bands connecting the neck and jaw (platysma bands) in adults. Administered by licensed medical specialists in 10-15 minute in-office sessions with minimal downtime; results visible in 24-48 hours, full results in 14-30 days, lasting up to 4 months.
- The Look of 3® A trademarked treatment protocol involving 64 units of BOTOX Cosmetic administered across three areas: 20 units for frown lines, 24 units for crow's feet (12 on each side), and 20 units for forehead lines. Treatments should be spaced at least 90 days apart and are intended for administration at least three times per year.
- Allē (Aesthetics Loyalty Program) A consumer loyalty program and provider directory mobile app (iOS and Google Play) that lets patients earn points on BOTOX Cosmetic treatments and over 50 other eligible products/services, redeemable for savings on qualifying aesthetic treatments. Includes exclusive member events like BOTOX Cosmetic Day and seasonal double-points offers.
Quantifiable outcome
- 61% and 46% of patients had ≥2-grade improvement at Day 30 for forehead lines
- +5 more outcomes
Companies that use BOTOX Cosmetic
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
BOTOX Cosmetic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BOTOX Cosmetic partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and core.
- Hello AliceflagshipHello Alice is a partner in The Confidence Collective initiative, a program by BOTOX Cosmetic that empowers women entrepreneurs. Through this partnership, 250 women entrepreneurs receive personalized mentorship and expert-led training through Boost Camp, a hands-on virtual accelerator. Hello Alice facilitates skill development in finance, marketing, leadership, and digital strategy.
- CherrycoreCherry provides the payment plan technology powering Allē Payment Plans, allowing patients to get treated now and pay over time in flexible monthly installments. No hard credit checks and no hidden fees. Cherry Technologies, Inc. issues these payment options through its lending partners.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
BOTOX Cosmetic competitors and assessment
Company assessmentDirect peers
- Xeomin (incobotulinumtoxinA): Merz Aesthetics' botulinum toxin type A injectable competing in the same facial aesthetic indications as BOTOX Cosmetic, marketed on a purified formulation without accessory proteins.
- Daxxify (daxibotulinumtoxinA-lanm): Revance Therapeutics' longer-duration botulinum toxin competing on duration-of-effect claims, targeting the same aesthetic provider channel and indications as BOTOX Cosmetic.
- Letybo (letibotulinumtoxinA): Hugel's botulinum toxin type A recently entering the US aesthetics market, competing on price and indication parity with BOTOX Cosmetic across glabellar and crow's feet lines.
- Dysport (abobotulinumtoxinA): Galderma's (formerly Ipsen) competing botulinum toxin type A injectable approved for aesthetic use, directly competing with BOTOX Cosmetic in frown lines and crow's feet indications with similar mechanism and provider channel.
- Jeuveau (prabotulinumtoxinA): Evolus's 'Newtox' aesthetic-only botulinum toxin directly targeting BOTOX Cosmetic's cosmetic indications at a competitive price point, primarily through the medical aesthetics provider channel.
Broad incumbents
- Sculptra: Galderma's PLLA collagen biostimulator operating in the same facial aesthetics provider channel as BOTOX Cosmetic, addressing aging facial volume rather than dynamic lines.
- Juvederm: Allergan Aesthetics' hyaluronic acid dermal filler portfolio — a sister brand under the same AbbVie/Allergan Aesthetics umbrella — competing in the broader facial aesthetics category that BOTOX Cosmetic operates in.
- Radiesse: Merz Aesthetics' CaHA-based filler and biostimulator serving the same provider channel and facial aesthetic patient base as BOTOX Cosmetic, often positioned as a complementary or alternative treatment.
- Restylane: Galderma's HA filler portfolio competing for the same provider channel and aesthetic patient base as BOTOX Cosmetic, often used adjunctively with neurotoxins in facial rejuvenation.
Others
- SkinMedica: Allergan Aesthetics' professional skincare brand — a sister brand under the same parent — that participates in the Allē loyalty ecosystem alongside BOTOX Cosmetic and serves the same aesthetic patient demographic.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BOTOX Cosmetic social profiles
Digital presenceBOTOX Cosmetic financial estimates
Financial estimateRevenue estimate
Valuation estimate
BOTOX Cosmetic leadership team
Management profileNumber of profiles
BOTOX Cosmetic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BOTOX Cosmetic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BOTOX Cosmetic
What does BOTOX Cosmetic do?
BOTOX Cosmetic (onabotulinumtoxinA) is a prescription injectable treatment that temporarily reduces underlying muscle activity to improve the appearance of moderate to severe frown lines, crow's feet, forehead lines, and vertical bands connecting the neck and jaw (platysma bands) in adults. The product is manufactured using a proprietary process and administered by licensed medical specialists in 10–15 minute sessions with minimal downtime, with results visible in 24–48 hours and full results within 14–30 days.
Is BOTOX Cosmetic a public or private company?
BOTOX Cosmetic is a private company. It is classified as corporate owned and is currently operating.
When was BOTOX Cosmetic founded?
BOTOX Cosmetic was founded in 2002. It employs 11 to 50 people.
Where is BOTOX Cosmetic based?
BOTOX Cosmetic is headquartered in Irvine, United States, in the North America region.
How does BOTOX Cosmetic make money?
One revenue line is on record: prescription Injectable Sales.
Who are BOTOX Cosmetic's main competitors?
Direct peers on record are Xeomin (incobotulinumtoxinA), Daxxify (daxibotulinumtoxinA-lanm), Letybo (letibotulinumtoxinA), Dysport (abobotulinumtoxinA) and Jeuveau (prabotulinumtoxinA). Broad incumbents are Sculptra, Juvederm, Radiesse and Restylane. SkinMedica is listed as an others.
Does BOTOX Cosmetic have an API?
No public API is recorded for BOTOX Cosmetic.
What industry is BOTOX Cosmetic in?
BOTOX Cosmetic's product category is Aesthetic Neurotoxin Injectables. Its primary akta.pro industry code is HLAKACAE, Cosmetic Dermatology (Aesthetic Injectables). Its NAICS code is 325414 and its SIC code is 2844.